ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryMedical technology manufacturerSchlierenClexBio AG
ClexBio AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

ClexBio AG develops regenerative tissue therapies using its VivoSet™ technology to create vascularized therapeutic tissues. Its pipeline includes tissues for treating liver failure, type 1 diabetes and heart muscle damage after a heart attack.

AI-generated
Presence

Service area

Offering

Products & services

Industry:Medical technology manufacturer
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.9/5

ClexBio AG

✓ Offered4
Tissue engineering and manufacturing platform (VivoSet)
Platform for producing therapeutic tissues from human cells with microvasculature and extracellular matrix. Injection molding and parallel, closed, automated bioreactor systems enable scalable manufacturing.
Liver tissue therapies
Fully vascularized liver tissues for acute and advanced liver failure or disease; the pipeline describes use as a bridge to transplant or recovery. Development stages include preclinical development and discovery.
Islet tissue therapy (CLX-200)
Fully vascularized islet tissue intended as responsive insulin replacement for Type 1 diabetes with hypoglycemia unawareness. The pipeline lists the program in the discovery stage.
Cardiac tissue therapy (CLX-300)
Fully vascularized cardiac tissue for tissue regeneration following myocardial infarction. The pipeline lists the CLX-300 program in the discovery stage.
Trust & reputation

ranQ Trust Score of ClexBio AG: 3.9 out of 5.0

Trust Score3.9/ 5.0

High

x

Data basis 54% · As of November 2026

ClexBio AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
ClexBio AG scores 59.7 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.39.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
ClexBio AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
ClexBio AG scores 45.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.45.74%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

ClexBio AG reaches a ranQ Trust Score of 3.9 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once ClexBio AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

ClexBio AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank ClexBio AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of ClexBio AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Zürcherstrasse 39d
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-374.833.454
Founded
2024 · 2 years
Last commercial register change
February 11, 2026
Employees
1 to 10

Active in 1 of 26 cantons

  • ZHZurich
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    IA
    InSphero AG
    Schlieren
    CA
    CUTISS AG
    Schlieren
    MG
    Mikrona Group AG
    Schlieren
    AM
    Artis Medical Group GmbH
    Schlieren
    TS
    Thoratec Switzerland GmbH
    Zurich
    XA
    Xeltis AG
    Zurich
    ID
    IntraVasa Diagnostics AG
    Erlenbach Zh
    VG
    Vantive GmbH
    Glattpark (Opfikon)